United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 17, 2026

On Sep 16, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$501.39 for US$4.76M under a trading plan, leaving 324,443 shares. Filed Sep 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$501.39 average (US$498.45 to US$505.20)
Value
US$4.76M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 16, 2026Common StockSale2,080US$498.45331,863Indirect
Sep 16, 2026Common StockSale1,220US$499.15330,643Indirect
Sep 16, 2026Common StockSale492US$500.19330,151Indirect
Sep 16, 2026Common StockSale708US$501.52329,443Indirect
Sep 16, 2026Common StockSale2,160US$502.44327,283Indirect
Sep 16, 2026Common StockSale1,538US$503.53325,745Indirect
Sep 16, 2026Common StockSale1,182US$504.17324,563Indirect
Sep 16, 2026Common StockSale120US$505.20324,443Indirect

Source

View original at SEC

Related